Wells Fargo & Company Tg Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 178,721 shares of TGTX stock, worth $5.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178,721

Previous 155,674 14.8%

Holding current value

$5.28 Million

Previous $2.77 Million 50.96%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.21 - $25.28 $396,638 - $582,628	23,047 Added 14.8%	178,721 $4.18 Million
Q2 2024 Aug 13, 2024	BUY	$13.32 - $19.19 $1.01 Million - $1.46 Million	75,851 Added 95.02%	155,674 $2.77 Million
Q1 2024 May 10, 2024	BUY	$13.02 - $21.3 $200,182 - $327,487	15,375 Added 23.86%	79,823 $1.21 Million
Q4 2023 Feb 09, 2024	SELL	$6.68 - $18.81 $976,382 - $2.75 Million	-146,165 Reduced 69.4%	64,448 $1.1 Million
Q3 2023 Nov 13, 2023	BUY	$8.36 - $26.5 $548,725 - $1.74 Million	65,637 Added 45.27%	210,613 $1.76 Million
Q2 2023 Aug 15, 2023	BUY	$15.48 - $35.0 $185,744 - $419,965	11,999 Added 9.02%	144,976 $3.6 Million
Q1 2023 May 12, 2023	BUY	$10.23 - $19.34 $1.07 Million - $2.01 Million	104,129 Added 360.96%	132,977 $2 Million
Q4 2022 Feb 13, 2023	SELL	$5.01 - $11.83 $33,792 - $79,793	-6,745 Reduced 18.95%	28,848 $341,000
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $49,598 - $91,165	-10,853 Reduced 23.37%	35,593 $211,000
Q2 2022 Aug 12, 2022	SELL	$3.74 - $10.66 $169,104 - $481,991	-45,215 Reduced 49.33%	46,446 $198,000
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $391,671 - $1.03 Million	-50,150 Reduced 35.36%	91,661 $872,000
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $723,656 - $1.69 Million	47,609 Added 50.54%	141,811 $2.7 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $572,683 - $1.06 Million	26,294 Added 38.72%	94,202 $3.14 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $1.73 Million - $2.6 Million	-53,174 Reduced 43.92%	67,908 $2.64 Million
Q1 2021 May 13, 2021	SELL	$41.61 - $54.3 $1.68 Million - $2.19 Million	-40,330 Reduced 24.99%	121,082 $5.84 Million
Q4 2020 Feb 09, 2021	BUY	$25.27 - $54.9 $718,400 - $1.56 Million	28,429 Added 21.38%	161,412 $8.4 Million
Q3 2020 Nov 05, 2020	BUY	$18.49 - $27.24 $78,046 - $114,980	4,221 Added 3.28%	132,983 $3.56 Million
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $601,168 - $1.48 Million	67,547 Added 110.34%	128,762 $2.51 Million
Q1 2020 May 14, 2020	BUY	$7.14 - $15.99 $437,075 - $978,827	61,215 New	61,215 $602,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Tg Therapeutics, Inc. Transaction History